A detailed history of Manufacturers Life Insurance Company, The transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 130,640 shares of ORIC stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
130,640
Previous 131,350 0.54%
Holding current value
$1.11 Million
Previous $928,000 44.29%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$7.52 - $11.9 $5,339 - $8,449
-710 Reduced 0.54%
130,640 $1.34 Million
Q2 2024

Aug 14, 2024

BUY
$6.63 - $12.93 $62,481 - $121,852
9,424 Added 7.73%
131,350 $928,000
Q1 2024

May 14, 2024

BUY
$8.04 - $16.03 $595,723 - $1.19 Million
74,095 Added 154.91%
121,926 $1.68 Million
Q4 2023

Feb 13, 2024

BUY
$5.41 - $9.43 $170,133 - $296,554
31,448 Added 191.96%
47,831 $440,000
Q2 2023

Aug 11, 2023

BUY
$4.95 - $8.4 $11,276 - $19,135
2,278 Added 16.15%
16,383 $127,000
Q2 2022

Aug 15, 2022

SELL
$2.7 - $7.07 $38,083 - $99,722
-14,105 Closed
0 $0
Q1 2022

Aug 11, 2023

BUY
$4.54 - $16.1 $64,036 - $227,090
14,105 New
14,105 $75,000
Q1 2022

May 20, 2022

SELL
$4.54 - $16.1 $12,966 - $45,981
-2,856 Reduced 16.84%
14,105 $75,000
Q4 2021

Feb 16, 2022

BUY
$12.01 - $20.3 $9,583 - $16,199
798 Added 4.94%
16,961 $249,000
Q3 2021

Nov 12, 2021

SELL
$15.9 - $25.22 $13,594 - $21,563
-855 Reduced 5.02%
16,163 $338,000
Q2 2021

Aug 12, 2021

BUY
$17.37 - $25.34 $71,911 - $104,907
4,140 Added 32.15%
17,018 $301,000
Q1 2021

May 03, 2021

SELL
$23.67 - $36.85 $686 - $1,068
-29 Reduced 0.22%
12,878 $316,000
Q4 2020

Feb 12, 2021

BUY
$20.32 - $39.8 $262,270 - $513,698
12,907 New
12,907 $437,000

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $336M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.